Daniel Schäfer

Title: The Innovative Contributions of Daniel Schäfer

Introduction

Daniel Schäfer is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). His work is instrumental in advancing therapeutic strategies for various diseases.

Latest Patents

Daniel Schäfer holds a patent for a chimeric antigen receptor that includes an antigen binding domain specific for an antigen, a spacer, a transmembrane domain, and an intracellular signaling domain. The spacer consists of C-set Ig-like domain(s), specifically from the sialic acid binding Ig-like lectin (Siglec) family. This innovative design enhances the functionality of CARs in immune cell therapies.

Career Highlights

Schäfer is currently associated with Miltenyi Biotec B.V. & Co. KG, a leading company in the field of biotechnology. His work at Miltenyi Biotec focuses on developing advanced cellular therapies that leverage the power of CAR technology. With a patent portfolio that includes 1 patent, he continues to push the boundaries of scientific research and application.

Collaborations

Daniel Schäfer collaborates with esteemed colleagues such as Rita Pfeifer and Ian Johnston. Their combined expertise fosters an environment of innovation and progress in the field of immunotherapy.

Conclusion

Daniel Schäfer's contributions to the field of biotechnology, particularly through his patented work on chimeric antigen receptors, highlight his role as a key innovator. His ongoing efforts at Miltenyi Biotec exemplify the impact of dedicated research in advancing medical therapies.